Teaching neuroimages: hydroxychloroquine-induced vacuolar myopathy.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 23733558.
- Also identified by DOI 10.1212/WNL.0b013e318295d6f4 and PMC identifier 3716356.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
A 58-year-old woman with long-standing mixed connective tissue disorder had proximal leg weakness for 4 months. She had been treated with 400 mg/day of hydroxychloroquine and varying doses of prednisone over 15 years. Creatine kinase was 600 U/mL. MRI of quadriceps showed edema and its biopsy revealed myriad acid-phosphatase–positive autophagic vacuoles indicating increased lysosomal activity (figure). Hydroxychloroquine induces autophagy by reducing lysosomal acidity.<sup>1</sup> Autophagic vacuolar myopathy can be seen with chloroquine or colchicine therapy or in inherited disorders (α-glucosidase deficiency, Danon disease, and X-linked myopathy with excessive autophagy).<sup>1</sup> Hydroxychloroquine myopathy usually presents with mild to moderate proximal weakness and rarely causes severe weakness and respiratory failure.<sup>2</sup> Our patient's weakness improved after discontinuing hydroxychloroquine.
Medical subject headings
- Hydroxychloroquine
- Lysosomal Storage Diseases
- Magnetic Resonance Imaging
- Muscular Diseases
- Quadriceps Muscle